Status:
COMPLETED
Vasopressin Use in Septic Shock From Türkiye
Lead Sponsor:
Karadeniz Technical University
Conditions:
Septic Shock
Vasodilatory Shock
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to examine the early hemodynamic effects and clinical outcomes of vasopressin use in patients with septic shock. The study aims to compare adult ICU patients wh...
Detailed Description
This is a single-center, retrospective observational cohort study designed to evaluate the clinical impact of adjunctive vasopressin therapy in adult patients with septic shock. The study protocol was...
Eligibility Criteria
Inclusion
- Adult patients (≥18 years old) admitted to the intensive care unit (ICU)
- Diagnosed with septic shock according to Sepsis-3 criteria
- Treated with norepinephrine as the initial vasopressor
- Received norepinephrine alone or norepinephrine with adjunctive vasopressin
- Admitted between January 1 and December 15, 2024
Exclusion
- Patients younger than 18 years
- Patients who received epinephrine or dopamine prior to or along with vasopressin
- Patients with incomplete clinical or hemodynamic data
- Readmitted ICU patients during the same hospitalization
- Patients with do-not-resuscitate (DNR) orders at ICU admission
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 15 2025
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT06953297
Start Date
January 1 2024
End Date
January 15 2025
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karadeniz Technical University, Faculty of Medicine
Trabzon, Turkey (Türkiye), 61080